A shortage of beds may be forcing hospitals to discharge patients with extensively drug-resistant tuberculosis (XDR-TB) before they are cured and a minority may be unwittingly infecting others, according to new research by Cape Town and Stellenbosch universities.
Published by the Treatment Action Campaign and Section27, the latest NSP Review looks at retention in care, health leadership and the role of citizen journalism in tracking progress against national targets.
Thembi Khabonina Nkomo, from Daantjie in Nelspruit, was diagnosed with HIV 13 years ago. She was afraid of being disowned by her family. She now credits her family’s love and support for her strength and happiness.
Budget cuts and poor financial management may be some of the culprits driving the country’s medicine stockouts.
More than ten percent of all health centres in the country have experienced stock outs of HIV and tuberculosis (TB) medicines in the last three months, jeopardising the health of millions of South African.
Erick Mudanalo from Limpopo has been taking tuberculosis (TB) treatment for three years but it was his recent HIV-positive diagnosis that almost caused him to give up hope altogether.
Released by a civil society consortium, this report shows that one-in-five health centers surveyed had experienced drug shortages or stock outs recently.
New research has shown that rapid GeneXpert tuberculosis (TB) test improves access to TB diagnosis and treatment, and may be ready for South African clinics.
A Cape Town survivor of extensively drug-resistant tuberculosis has taken her campaign for better access to testing and treatment from her hometown of Khayelitsha to Paris and beyond.
Diagnosed cases of multidrug-resistant tuberculosis (MDR-TB) have nearly doubled globally but treatment in countries like South Africa’s is not keeping up, leaving patients to die and communities at risk, according to a new World Health Organisation (WHO) report.